These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6936607

  • 21. Acute promyelocytic leukemia in 57 previously untreated patients.
    Cordonnier C, Vernant JP, Brun B, Heilmann MG, Kuentz M, Bierling P, Farcet JP, Rodet M, Duedari N, Imbert M.
    Cancer; 1985 Jan 01; 55(1):18-25. PubMed ID: 3855265
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Acute promyelocytic leukemia. M.D. Anderson Hospital experience.
    Kantarjian HM, Keating MJ, Walters RS, Estey EH, McCredie KB, Smith TL, Dalton WT, Cork A, Trujillo JM, Freireich EJ.
    Am J Med; 1986 May 01; 80(5):789-97. PubMed ID: 3458366
    [Abstract] [Full Text] [Related]

  • 26. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM, Liebman HA, Patch MJ, Teitelbaum A, Levine AM, Feinstein DI.
    Cancer; 1983 Feb 15; 51(4):681-5. PubMed ID: 6571800
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T, Watanabe J, Honda G, Mimuro J, Takahashi H, Tsuji H, Eguchi Y, Kitajima I, Sakata Y.
    Thromb Res; 2014 May 15; 133(5):772-81. PubMed ID: 24636871
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.
    Uchiumi H, Matsushima T, Yamane A, Doki N, Irisawa H, Saitoh T, Sakura T, Jimbo T, Handa H, Tsukamoto N, Karasawa M, Miyawaki S, Murakami H, Nojima Y.
    Int J Hematol; 2007 Aug 15; 86(2):137-42. PubMed ID: 17875527
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V, Savić A.
    Med Pregl; 2014 Aug 15; 67(3-4):83-90. PubMed ID: 24961049
    [Abstract] [Full Text] [Related]

  • 40. Disseminated intravascular coagulation in acute promyelocytic leukemia. Possibility of treatment with glucocorticoids at high doses.
    Leone G, Mango G, Alfano G.
    Nouv Rev Fr Hematol (1978); 1978 Nov 25; 20(3):395-401. PubMed ID: 289100
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.